Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Salesforce.com Inc

CRM

Salesforce.com Inc

Salesforce.com Inc historical holders

total: 22

Meritage Group Salesforce.com Inc transactions over time

Total transactions:
22
New positions:
2
Sold out:
2
Added:
8
Reduced:
10
Held since:
2019 Q4
Held for:
19 quarters
Latest activity:
2024 Q3
Nathaniel Simons has been an institutional investor in Salesforce.com Inc (CRM) since 2016 Q4. According to 2026 Q1 report, Nathaniel Simons doesn't hold any shares. The fund/company first acquired CRM in 2016 Q4, initially purchasing 17,797 shares. Nathaniel Simons later completely sold out the position and reinvested in CRM again in 2019 Q4. Since the initial investment, Meritage Group has made 21 more transactions in this position.

When did Nathaniel Simons exit their CRM position?

Nathaniel Simons no longer holds Salesforce.com Inc (CRM). They sold off their entire position in 2024 Q3, closing out an investment that began in 2016 Q4.

When did Nathaniel Simons first invest in CRM?

Nathaniel Simons first invested in Salesforce.com Inc (CRM) in 2016 Q4 at the reported quarter-end price of $68.44 per share, acquiring 17,797 shares in their initial purchase.

What is Nathaniel Simons's average cost basis for CRM?

Based on historical transaction data, Nathaniel Simons's estimated cost basis for Salesforce.com Inc (CRM) is approximately $180.52 per share. This represents their average reported price* across all buy transactions.

Has Nathaniel Simons reinvested in CRM after selling?

Yes, Nathaniel Simons has shown renewed interest in Salesforce.com Inc (CRM). After completely selling their position, they reinitiated an investment in 2019 Q4, demonstrating continued conviction in this ticker.

Estimated cost basis*

Weighted AVG buy price:
$180.52
Weighted AVG sell price:
$231.28

CRM transactions history by Meritage Group

22 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2024 Q3
0.00%
0
$257.10
-100% (-1,243)
-0.01%
2024 Q2
0.01%
1,243
$257.10
$319,575
-98.58% (-86,094)
-0.52%
2024 Q1
0.62%
87,337
$301.18
$26,304,000
-91.63% (-955,949)
-6.63%
2023 Q4
6.32%
1,043,286
$263.14
$274,530,000
+0.46% (+4,793)
+0.03%
2023 Q3
5.76%
1,038,493
$202.78
$210,586,000
-35.49% (-571,359)
-3.23%
2023 Q2
9.48%
1,609,852
$211.26
$340,097,000
-33.10% (-796,536)
-5.09%
2023 Q1
14.54%
2,406,388
$199.78
$480,748,000
+0.53% (+12,587)
+0.08%
2022 Q4
10.95%
2,393,801
$132.59
$317,394,000
+31.97% (+579,871)
+2.65%
2022 Q3
9.28%
1,813,930
$143.84
$260,916,000
+1.45% (+25,905)
+0.13%
2022 Q2
8.52%
1,788,025
$165.04
$295,096,000
-25.01% (-596,388)
-2.11%
2022 Q1
10.85%
$212.32
-0.03% (-618)
2021 Q4
12.08%
$254.13
-1.50% (-36,390)
2021 Q3
12.94%
$271.22
-1.69% (-41,661)
2021 Q2
11.28%
$244.27
+12.10% (+265,811)
2021 Q1
8.92%
$211.87
+68.07% (+889,880)
2020 Q4
5.70%
$222.53
-17.74% (-281,934)
2020 Q3
7.60%
$251.32
-7.65% (-131,581)
2020 Q2
6.81%
$187.33
+73.63% (+729,767)
2020 Q1
3.88%
$143.98
+27.60% (+214,403)
2019 Q4
2.58%
$162.64
new
2017 Q1
0.00%
$68.44
-100% (-17,797)
2016 Q4
0.04%
$68.44
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.